Press Releases Microbix Biosystems Inc.

Equities

Market Closed - Toronto S.E. Other stock markets 03:00:11 2024-07-11 pm EDT			5-day change	1st Jan Change
0.31 ^CAD	0.00%		+1.64%	-20.51%

Jun. 17	Microbix Biosystems Inc. Celebrates Opening of Two Expansions to Its Medical Devices Manufacturing Capacity At One of Its Three Adjacent Mississauga Sites	CI
Jun. 04	Microbix Advancing Test-Ingredient Manufacturing Capabilities	MT

Microbix Hosts Minister Nina Tangri to Open Capacity Expansions	Jun. 17	GL
Microbix Hosts Minister Nina Tangri to Open Capacity Expansions	Jun. 17	AQ
Microbix Advances Test-Ingredient Manufacturing Capabilities	Jun. 04	GL
Microbix Reports Strong Results for Q2 Fiscal 2024	May. 15	GL
Microbix Schedules Release of Results for Q2 Fiscal 2024	May. 08	GL
Microbix Collaborator Introduces New Lab Accreditation Program	Apr. 25	GL
Microbix Presenting at the 2024 Bloom Burton Conference	Apr. 11	GL
Microbix Announces Annual and Special Meeting Voting Results	Apr. 01	GL
Microbix’s Clot-Buster Drug Project Advances	Mar. 14	GL
Microbix Unveils Test Controls for Head and Neck Cancer	Mar. 11	GL
Microbix Unveils Test Controls for Head and Neck Cancer	Mar. 11	AQ
Microbix Announces Issuance of Stock Options	Feb. 26	GL
Microbix Reports Record Results for Q1 Fiscal 2024	Feb. 14	GL
Microbix Schedules Release of Results for Q1 Fiscal 2024	Feb. 07	GL
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen	Feb. 06	AQ
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen	Feb. 06	GL
Microbix Achieves Further QAPs Sales Record	Jan. 03	GL
Microbix Achieves Further QAPs Sales Record	Jan. 03	AQ
Microbix Reports Results for Q4 & Full-Year Fiscal 2023	Dec. 21	GL
Microbix Biosystems : Reports Results for Q4 & Full-Year Fiscal 2023	Dec. 21	PU

No results for this search